FDA Warns About a Liver Medication After 19 Deaths

The FDA has issued a warning about a liver disease medication after 19 reported fatalities were linked to incorrect dosing.

Ocaliva (obeticholic acid) is prescribed to people with a chronic liver disease known as primary biliary cholangitis (PBC). The FDA believes the 19 patients received an overdose of the medication. In addition, 11 cases of serious liver injury related to Ocaliva use were reported to the FDA.

The drug’s label information recommends that a patient should not take more than 10 mg twice a week. However, it was reported that 7 patients with moderate to severe liver disease received 5 mg of Ocaliva daily. What’s even more alarming is that patients with milder liver disease were prescribed this medication, and may have experienced liver injury after receiving the correct dose of Ocaliva.

The agency urges patients to closely monitor the onset of possible side effects and contact their doctor if they begin to experience the following symptoms that may be associated with liver damage:

  • New or worsening fatigue
  • Diarrhea
  • Weight loss
  • Abdominal pain
  • Decreased appetite
  • Nausea and vomiting
  • Change in behavior or confusion
  • Vague symptoms such as anxiety or unease
  • Abdominal swelling
  • Yellow eyes or skin
  • Bloody stools

Alanna McCatty

Alanna McCatty

Alanna McCatty is founder and CEO of McCatty Scholars, an organization that devises and implements financial literacy programs for students to combat the nationwide issue of the loss of educational opportunity due to the ramifications of burdensome student debt. At MedShadow, she reports on new findings and research on the side effects of prescription drugs. She is a graduate of Pace University.


Did you find this article helpful?


Latest News

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

Can Convalescent Plasma Treat COVID-19 Patients?

Can Convalescent Plasma Treat COVID-19 Patients?

One of the most promising treatments for COVID-19 is convalescent plasma, a component of blood. People who have been infected with the virus and are now healthy have developed COVID-19-fighting antibodies, which, the theory is, can be given to people currently sick with COVID-19 so that those antibodies can boost…

  • Advertisement